The relationship between fasting serum glucose and cerebral glucose metabolism in late-life depression and normal aging

[1]  T. Ninomiya,et al.  Diabetes Mellitus and Dementia , 2014, Current Diabetes Reports.

[2]  G. Alexander,et al.  Higher serum glucose levels are associated with cerebral hypometabolism in Alzheimer regions , 2013, Neurology.

[3]  T. Montine,et al.  Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial , 2011 .

[4]  David Eidelberg,et al.  Distinct functional networks associated with improvement of affective symptoms and cognitive function during citalopram treatment in geriatric depression , 2011, Human brain mapping.

[5]  S. Minoshima,et al.  Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. , 2011, Archives of neurology.

[6]  V. Basevi.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[7]  Eva L. Feldman,et al.  How does diabetes accelerate Alzheimer disease pathology? , 2010, Nature Reviews Neurology.

[8]  T. Pollmächer,et al.  Glucose Tolerance in Depressed Inpatients, under Treatment with Mirtazapine and in Healthy Controls , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[9]  Gwenn S. Smith,et al.  The functional neuroanatomy of geriatric depression , 2009, International journal of geriatric psychiatry.

[10]  David Eidelberg,et al.  Serotonin Modulation of Cerebral Glucose Metabolism in Depressed Older Adults , 2009, Biological Psychiatry.

[11]  et al.,et al.  Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI) , 2009, NeuroImage.

[12]  M. Deuschle,et al.  Improved insulin sensitivity in 51 nondiabetic depressed inpatients remitting during antidepressive treatment with mirtazapine and venlafaxine. , 2008, Journal of clinical psychopharmacology.

[13]  P. Mehta,et al.  Intranasal insulin improves cognition and modulates β-amyloid in early AD , 2008, Neurology.

[14]  David Loewenstein,et al.  Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. , 2006, Archives of general psychiatry.

[15]  B. Pollock,et al.  Persistence of neuropsychologic deficits in the remitted state of late-life depression. , 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[16]  M. Haan.  Therapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease , 2006, Nature Clinical Practice Neurology.

[17]  G. Schellenberg,et al.  Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype , 2006, Neurobiology of Aging.

[18]  S. Bandinelli,et al.  Insulin Resistance and Executive Dysfunction in Older Persons , 2004, Journal of the American Geriatrics Society.

[19]  Suzanne Craft,et al.  Insulin and neurodegenerative disease: shared and specific mechanisms , 2004, The Lancet Neurology.

[20]  Anna Barnes,et al.  Serotonin modulation of cerebral glucose metabolism in normal aging , 2004, Neurobiology of Aging.

[21]  N. Rasgon,et al.  Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

[22]  G. Alexopoulos.  "The depression-executive dysfunction syndrome of late life": a specific target for D3 agonists? , 2001, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[23]  P. Jerabek,et al.  Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response , 2000, Biological Psychiatry.

[24]  M. Hongo,et al.  Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. , 2000, Metabolism: clinical and experimental.

[25]  Sanjay Asthana,et al.  Insulin Metabolism in Alzheimer’s Disease Differs According to Apolipoprotein E Genotype and Gender , 1999, Neuroendocrinology.

[26]  G. Alexopoulos,et al.  'Vascular depression' hypothesis. , 1997, Archives of general psychiatry.

[27]  K. Krishnan,et al.  MRI-defined vascular depression. , 1997, The American journal of psychiatry.

[28]  D. Ford,et al.  Depression and Risk for Onset of Type II Diabetes: A prospective population-based study , 1996, Diabetes Care.

[29]  P. Duberstein,et al.  Relationships of age and axis I diagnoses in victims of completed suicide: a psychological autopsy study. , 1996, The American journal of psychiatry.

[30]  G. Alexopoulos,et al.  Disability in geriatric depression. , 1996, The American journal of psychiatry.

[31]  S. Thibodeau,et al.  Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. , 1996, The New England journal of medicine.

[32]  J. Lönnqvist,et al.  Mental Disorders in Elderly Suicide , 1995, International Psychogeriatrics.

[33]  G. Alexopoulos,et al.  The course of geriatric depression with "reversible dementia": a controlled study. , 1993, The American journal of psychiatry.

[34]  G. Alexopoulos,et al.  Geriatric depression: Age of onset and dementia , 1993, Biological Psychiatry.

[35]  V. Dhawan,et al.  Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curve. , 1993, Radiology.

[36]  F. Fazekas,et al.  Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter. A comparative study between stroke patients and normal volunteers. , 1992, Archives of neurology.

[37]  J D Brodie,et al.  Reproducibility of Cerebral Glucose Metabolic Measurements in Resting Human Subjects , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  J. Amsterdam,et al.  Insulin resistance after oral glucose tolerance testing in patients with major depression. , 1988, The American journal of psychiatry.

[39]  P. Mueller,et al.  Differential response of plasma glucose, amino acids and nonesterified fatty acids to insulin in depressed patients , 1984, Psychoneuroendocrinology.

[40]  G. Asnis,et al.  Relative insulin insensitivity and cortisol secretion in depressed patients , 1981, Psychiatry Research.

[41]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[42]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[43]  M. Reger,et al.  Intranasal insulin improves cognition and modulates beta-amyloid in early AD. , 2008, Neurology.

[44]  C. Jack,et al.  Alzheimer's Disease Neuroimaging Initiative , 2008 .

[45]  Diagnosis and Classification of Diabetes Mellitus , 2003 .

[46]  M. Takeda,et al.  [Vascular depression]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.

[47]  G. V. Van Hoesen,et al.  The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. , 1991, Cerebral cortex.

[48]  D. Lewis.  Insulin tolerance test in depression. , 1985, Psychiatric medicine.